Selected research
Market Analysis & Forecast
Global Tiapride Hydrochloride Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Tiapride Hydrochloride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tiapride Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Tiapride Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Tiapride Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Tiapride Hydrochloride Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Tiapride Hydrochloride Tablets include Jiangsu Nhwa Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, Astellas Pharma, Tasly Pharmaceuticals, Sawai Pharmaceutical, Nihon Generic and Grand Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Tiapride Hydrochloride Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Tiapride Hydrochloride Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Tiapride Hydrochloride Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tiapride Hydrochloride Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tiapride Hydrochloride Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tiapride Hydrochloride Tablets sales, projected growth trends, production technology, application and end-user industry.
Tiapride Hydrochloride Tablets Segment by Company
Jiangsu Nhwa Pharmaceutical
Tianjin Pharmaceutical Da Ren Tang Group
Astellas Pharma
Tasly Pharmaceuticals
Sawai Pharmaceutical
Nihon Generic
Grand Pharmaceutical
Tiapride Hydrochloride Tablets Segment by Type
100mg
50mg
Tiapride Hydrochloride Tablets Segment by Application
Hospital
Clinic
Others
Tiapride Hydrochloride Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tiapride Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tiapride Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tiapride Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Tiapride Hydrochloride Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Tiapride Hydrochloride Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tiapride Hydrochloride Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100mg
- 50mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- Jiangsu Nhwa Pharmaceutical
- Tianjin Pharmaceutical Da Ren Tang Group
- Astellas Pharma
- Tasly Pharmaceuticals
- Sawai Pharmaceutical
- Nihon Generic
- Grand Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Tiapride Hydrochloride Tablets Market by Type
- 1.2.1 Global Tiapride Hydrochloride Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 100mg
- 1.2.3 50mg
- 1.3 Tiapride Hydrochloride Tablets Market by Application
- 1.3.1 Global Tiapride Hydrochloride Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Tiapride Hydrochloride Tablets Market Dynamics
- 2.1 Tiapride Hydrochloride Tablets Industry Trends
- 2.2 Tiapride Hydrochloride Tablets Industry Drivers
- 2.3 Tiapride Hydrochloride Tablets Industry Opportunities and Challenges
- 2.4 Tiapride Hydrochloride Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Tiapride Hydrochloride Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Tiapride Hydrochloride Tablets Revenue by Region
- 3.2.1 Global Tiapride Hydrochloride Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Tiapride Hydrochloride Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Tiapride Hydrochloride Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Tiapride Hydrochloride Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Tiapride Hydrochloride Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Tiapride Hydrochloride Tablets Sales by Region
- 3.4.1 Global Tiapride Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Tiapride Hydrochloride Tablets Sales by Region (2021-2026)
- 3.4.3 Global Tiapride Hydrochloride Tablets Sales by Region (2027-2032)
- 3.4.4 Global Tiapride Hydrochloride Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Tiapride Hydrochloride Tablets Revenue by Manufacturers
- 4.1.1 Global Tiapride Hydrochloride Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Tiapride Hydrochloride Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Tiapride Hydrochloride Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Tiapride Hydrochloride Tablets Sales by Manufacturers
- 4.2.1 Global Tiapride Hydrochloride Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Tiapride Hydrochloride Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Tiapride Hydrochloride Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Tiapride Hydrochloride Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Tiapride Hydrochloride Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Tiapride Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Tiapride Hydrochloride Tablets Manufacturers, Product Type & Application
- 4.7 Global Tiapride Hydrochloride Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Tiapride Hydrochloride Tablets Market CR5 and HHI
- 4.8.2 2025 Tiapride Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
5 Tiapride Hydrochloride Tablets Market by Type
- 5.1 Global Tiapride Hydrochloride Tablets Revenue by Type
- 5.1.1 Global Tiapride Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Tiapride Hydrochloride Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Tiapride Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Tiapride Hydrochloride Tablets Sales by Type
- 5.2.1 Global Tiapride Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Tiapride Hydrochloride Tablets Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Tiapride Hydrochloride Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Tiapride Hydrochloride Tablets Price by Type
6 Tiapride Hydrochloride Tablets Market by Application
- 6.1 Global Tiapride Hydrochloride Tablets Revenue by Application
- 6.1.1 Global Tiapride Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Tiapride Hydrochloride Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Tiapride Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Tiapride Hydrochloride Tablets Sales by Application
- 6.2.1 Global Tiapride Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Tiapride Hydrochloride Tablets Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Tiapride Hydrochloride Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Tiapride Hydrochloride Tablets Price by Application
7 Company Profiles
- 7.1 Jiangsu Nhwa Pharmaceutical
- 7.1.1 Jiangsu Nhwa Pharmaceutical Company Information
- 7.1.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 7.1.3 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
- 7.1.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 7.2 Tianjin Pharmaceutical Da Ren Tang Group
- 7.2.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
- 7.2.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
- 7.2.3 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Product Portfolio
- 7.2.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
- 7.3 Astellas Pharma
- 7.3.1 Astellas Pharma Company Information
- 7.3.2 Astellas Pharma Business Overview
- 7.3.3 Astellas Pharma Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Astellas Pharma Tiapride Hydrochloride Tablets Product Portfolio
- 7.3.5 Astellas Pharma Recent Developments
- 7.4 Tasly Pharmaceuticals
- 7.4.1 Tasly Pharmaceuticals Company Information
- 7.4.2 Tasly Pharmaceuticals Business Overview
- 7.4.3 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Product Portfolio
- 7.4.5 Tasly Pharmaceuticals Recent Developments
- 7.5 Sawai Pharmaceutical
- 7.5.1 Sawai Pharmaceutical Company Information
- 7.5.2 Sawai Pharmaceutical Business Overview
- 7.5.3 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
- 7.5.5 Sawai Pharmaceutical Recent Developments
- 7.6 Nihon Generic
- 7.6.1 Nihon Generic Company Information
- 7.6.2 Nihon Generic Business Overview
- 7.6.3 Nihon Generic Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Nihon Generic Tiapride Hydrochloride Tablets Product Portfolio
- 7.6.5 Nihon Generic Recent Developments
- 7.7 Grand Pharmaceutical
- 7.7.1 Grand Pharmaceutical Company Information
- 7.7.2 Grand Pharmaceutical Business Overview
- 7.7.3 Grand Pharmaceutical Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Grand Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
- 7.7.5 Grand Pharmaceutical Recent Developments
8 North America
- 8.1 North America Tiapride Hydrochloride Tablets Market Size by Type
- 8.1.1 North America Tiapride Hydrochloride Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Tiapride Hydrochloride Tablets Sales by Type (2021-2032)
- 8.1.3 North America Tiapride Hydrochloride Tablets Price by Type (2021-2032)
- 8.2 North America Tiapride Hydrochloride Tablets Market Size by Application
- 8.2.1 North America Tiapride Hydrochloride Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Tiapride Hydrochloride Tablets Sales by Application (2021-2032)
- 8.2.3 North America Tiapride Hydrochloride Tablets Price by Application (2021-2032)
- 8.3 North America Tiapride Hydrochloride Tablets Market Size by Country
- 8.3.1 North America Tiapride Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Tiapride Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Tiapride Hydrochloride Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Tiapride Hydrochloride Tablets Market Size by Type
- 9.1.1 Europe Tiapride Hydrochloride Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Tiapride Hydrochloride Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Tiapride Hydrochloride Tablets Price by Type (2021-2032)
- 9.2 Europe Tiapride Hydrochloride Tablets Market Size by Application
- 9.2.1 Europe Tiapride Hydrochloride Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Tiapride Hydrochloride Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Tiapride Hydrochloride Tablets Price by Application (2021-2032)
- 9.3 Europe Tiapride Hydrochloride Tablets Market Size by Country
- 9.3.1 Europe Tiapride Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Tiapride Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Tiapride Hydrochloride Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Tiapride Hydrochloride Tablets Market Size by Type
- 10.1.1 China Tiapride Hydrochloride Tablets Revenue by Type (2021-2032)
- 10.1.2 China Tiapride Hydrochloride Tablets Sales by Type (2021-2032)
- 10.1.3 China Tiapride Hydrochloride Tablets Price by Type (2021-2032)
- 10.2 China Tiapride Hydrochloride Tablets Market Size by Application
- 10.2.1 China Tiapride Hydrochloride Tablets Revenue by Application (2021-2032)
- 10.2.2 China Tiapride Hydrochloride Tablets Sales by Application (2021-2032)
- 10.2.3 China Tiapride Hydrochloride Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Tiapride Hydrochloride Tablets Market Size by Type
- 11.1.1 Asia Tiapride Hydrochloride Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Tiapride Hydrochloride Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Tiapride Hydrochloride Tablets Price by Type (2021-2032)
- 11.2 Asia Tiapride Hydrochloride Tablets Market Size by Application
- 11.2.1 Asia Tiapride Hydrochloride Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Tiapride Hydrochloride Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Tiapride Hydrochloride Tablets Price by Application (2021-2032)
- 11.3 Asia Tiapride Hydrochloride Tablets Market Size by Country
- 11.3.1 Asia Tiapride Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Tiapride Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Tiapride Hydrochloride Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Tiapride Hydrochloride Tablets Market Size by Type
- 12.1.1 SAMEA Tiapride Hydrochloride Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Tiapride Hydrochloride Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Tiapride Hydrochloride Tablets Price by Type (2021-2032)
- 12.2 SAMEA Tiapride Hydrochloride Tablets Market Size by Application
- 12.2.1 SAMEA Tiapride Hydrochloride Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Tiapride Hydrochloride Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Tiapride Hydrochloride Tablets Price by Application (2021-2032)
- 12.3 SAMEA Tiapride Hydrochloride Tablets Market Size by Country
- 12.3.1 SAMEA Tiapride Hydrochloride Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Tiapride Hydrochloride Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Tiapride Hydrochloride Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Tiapride Hydrochloride Tablets Value Chain Analysis
- 13.1.1 Tiapride Hydrochloride Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Tiapride Hydrochloride Tablets Production Mode & Process
- 13.2 Tiapride Hydrochloride Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Tiapride Hydrochloride Tablets Distributors
- 13.2.3 Tiapride Hydrochloride Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst